Efficacy Evaluation in 10 years treatment
Objective efficacy - Scalp photographs
The proportions of patients with improvement (MGPA ≥ 5) or prevention of disease progression (MGPA ≥ 4) at treatment year 10 were 91.5% (487/532) and 99.1% (527/532), respectively. The efficacy evaluation showed that the MGPA improved significantly from year 1 through to year 10 of treatment compared with the baseline (MGPA = 4).
呢句唔係話對比baseline九成人都有好轉/冇惡化?